Prof. Siret Ratip


Hematologist , Experience: 30 Years

Book Appointment

About Doctor

EDUCATION

2000 Marmara University Faculty of Medicine / Associate Professor

1998 Marmara University Faculty of Medicine Hematology

1994 Marmara University Faculty of Medicine Internal Medicine

1987 King’s College School of Medicine

EXPERIENCE

2002 Acıbadem Healthcare Group

2000 Marmara University Faculty of Medicine Hospital

1998 Marmara University Faculty of Medicine Hospital

1996 – 1996 University College Hospital, London / PhD in Hematology

1996 – 2002 Marmara University Faculty of Medicine

1996 University College Hospital

1995 – 1998 Marmara University Faculty of Medicine Hospital

1994 – 1995 University College Hospital, London

1994 – 1995 University College Hospital

1993 – 1993 Master of Clinical Genetics, Institute of Child Health, London

Hospital

Acibadem University Hospital, Istanbul, Turkey

Specialization

  • Thalassemia
  • Hematological Disorders
  • Sickle Cell Disease
  • Neuromuscular Disorders
  • Multiple Myeloma
  • Lymphoma
  • Various Autoimmune Diseases
  • Acute Lymphocytic Leukemia
  • Aplastic Anemia
  • Spinal Injury
  • Congenital Neutropenia
  • Acute Myelogenous Leukemia (AMI)
  • Orthopedic Conditions

Procedures Performed

  • Bone marrow transplant

Research & Publications

  • Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients. 35, 380-8. Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB, Karti SS
  • Crimean-Congo hemorrhagic fever in Turkey.Ksiazeg TG. Emerg Infect Dis. 2004 Aug;10(8):1379-84. Karti SS, Odabasi Z, orten V, Yilmaz M, Sonmez M, Caylan R, Akdogan E, Eren N, Koksal I, Ovali E, Erickson BR, Vincent MJ, Nichol ST, Comer JA, Rollin PE,
  • Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparinHepato-Gastroenterology. 50, 1864-6 (2003). Karti SS, Ovali E, Ozgur O, Yilmaz M, Sonmez M, Ratip S, Ozdemir F.
  • Philedelphia negative, bcr-abl positive Chronic myeloid leukemia associated with pure red cell Aplasia.Journal of Experimental and Clinical Canser Research, 22, 341-342 (2003), Kartı S.S., Yilmaz M., Sönmez M., Akdoğan R., Ersöz Ş., Uçar F., Ovalı E.
  • Early medical treatment is life saving in acute Budd-Chiari due to polycythemia vera.Hepato-Gastroenterology 50, 512-4 (2003). Kartı SS, Yılmaz M, Kosucu P, Altun E, Kesen J, Arslan M, Özgür O, Ovalı E.
  • Blood coagulation and fibrinolytic activity in hypothyroidism.International Journal of Clinical Practice, 57, 78-81 (2003) Erem C., Kavgacı H., Ersöz H.Ö., Hacıhasanoğlu A., Ukinç K., Kartı S.S., Değer O., Telatar M.
  • Clinical Microbiological case: chronic disseminated candidiasis unresponsive to treatment.Clinical Microbiology and Infection, 8, 435-436, 442-444 (2002). Ratip S, Odabaşı Z, Kartı SS, Çetiner M, Yeğen C, Çerikçioğlu N, Bayık M, Korten V.
  • Noncardiogenic pulmonary edema in the course of verapamil intoxication.Emergency Medicine Journal, 19, 458-459 (2002). Kartı S.S., Ulusoy H, Yandı M, Gündüz A, Koşucu M, Erol K, Ratip S.
  • Effect of Interferon ?2a on reutrophil adhesion and phagocytosis in chronic myeloid leukemia and Behçet?s disease.Clin Rheumatol, 21, 211-214 (2002). . Kartı S. S., Ovalı E, Ratip S, Çetiner M, Direskeneli H, Bayık M, Akoğlu T,

Role of hepatocyte growth factor in the development of dendritic cells from CD34+ bone marrow cells.Haematologica, 85, 464-469 (2000). Ovalı E., Ratip S., Kıbaroğlu A., Tekelioğlu Y., Çetiner M., Kartı S.S., Aydın F., Bayık M., Akoğlu T.

 

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

×
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy